🇺🇸 FDA
Patent

US 10584356

Multigenome retroviral vector preparations and methods and systems for producing and using same

granted A61KA61K2039/5256A61K2039/70

Quick answer

US patent 10584356 (Multigenome retroviral vector preparations and methods and systems for producing and using same) held by IMMUNE DESIGN CORP. expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IMMUNE DESIGN CORP.
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/5256, A61K2039/70, A61K39/0011, A61K39/001102